Key Catalyst: According to recent reports, WBA shares rose 6% following news that Sycamore Partners is exploring a $10 billion financing package for a potential acquisition. The private equity firm is working with Morgan Stanley and UBS on the financing structure, which would include term loans, bridge loans, and asset-based lending.

Fundamental Analysis:

Business Segments:

Analyst Perspective: Recent analyst coverage shows:

Leerink Partners maintains Hold rating
Price target: $11.50
Consensus rating: Hold
Average price target: $11.63

Investment Considerations:

Positive catalysts: Potential buyout speculation and financing arrangements
Risks: Trading near 52-week lows, challenging retail environment
Valuation metrics show:
- P/E: 7x
- EV/EBITDA: 8.64x
- Dividend Yield: 5.45%

Recommendation: Given the recent buyout speculation and significant price movement, WBA could present a speculative buying opportunity. However, investors should be aware that merger arbitrage situations carry inherent risks if deals don't materialize.

What is price prediction 2025 for WBA Stock?

Based on the provided data and recent market analysis, here is the price prediction for WBA stock in 2025:

WBA stock is expected to reach $11.13 by end of 2025, representing an 8.3% upside from current levels, according to the consensus of 15 Wall Street analysts. The stock has shown signs of stabilization after a challenging 2024, with a 10.2% YTD gain in early 2025 outpacing the S&P 500's 2.7% rise.

The recent dividend suspension announced in January 2025 and ongoing restructuring efforts are expected to improve cash flow and reduce debt, though earnings are projected to decline 44.4% year-over-year to $1.60 per share for fiscal year 2025. The company's cost-cutting initiatives and focus on profitability could support gradual price recovery, despite near-term headwinds.

What is surpport and resistant level for WBA Stock?

The S1 support level for WBA Stock is $9.61 ,The R1 resistant level for WBA Stock is $11.25.

What is the current price of WBA Stock?

As of the end of day on 2025-02-26, the price of WBA Stock was $11.08.

What is the target price of WBA Stock?

The target price for WBA Stock according to analyst rating is 11.63, with the highest price target at 15.00 and the lowest at 7.00. Analysts have a Hold rating on WBA Stock overall.

What is the market cap of Walgreens Boots Alliance Inc?

The market cap of WBA is $9.5B.

Is Walgreens Boots Alliance Inc (WBA) overvalued?

Based on the provided data and recent market analysis, WBA is currently undervalued when considering traditional metrics but faces significant operational challenges. The stock trades at a forward P/E of 6.09, below the S&P 500 average but above its industry average of 4.58. The company's recent dividend suspension after 90 years and significant stock decline of 54.8% over the past year signal serious financial concerns. The company reported an operating loss of $245 million in Q1 FY2025, with continued cash burn of $140 million from operations. The mean analyst price target of $11.13 suggests only modest upside potential of 8.3% from current levels. Technical indicators show neutral RSI levels around 47.87 with price consolidating near support levels.

What is Walgreens Boots Alliance Inc (WBA)'s business?

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

What is price prediction 2030 for WBA Stock?

Based on the provided data and market research, here's a price prediction analysis for WBA stock by 2030:

WBA stock is projected to reach $15-17 by 2030, representing a 40-58% increase from current levels, driven by the company's turnaround strategy and healthcare segment growth. The stock has faced significant headwinds recently, dropping 54.8% over the past year, but analysts expect earnings to stabilize after fiscal 2025's projected 44.4% decline. The successful execution of debt reduction plans and store optimization initiatives will be crucial for this price target.

The current mean analyst price target is $11.13 with a street-high target of $15, suggesting near-term upside potential. However, the company's recent dividend suspension after 90 years indicates significant financial restructuring ahead that could impact medium-term growth.